- Introduction: Restless Leg Syndrome13:51Introduction: Amazing Animals1:16Things I Do, But Should I? NSAIDS for Biliary Colic5:58Paper Chase 1: Pimavanserin - A New Treatment for Parkinson’s Disease Psychosis4:57Somatic Symptom Disorders20:19Anemia Deep Dive: MacrocytosisFree Chapter21:17Palliative Care: Management of Vomiting20:26Paper Chase 2: Treating Rheumatoid Arthritis When Methotrexate Monotherapy Fails5:24Amazing Animals: Gila Monster3:23Functional Pain Syndromes: Fibromyalgia and Chronic Fatigue12:24Shawn Hersevoort - Inside Out2:26Paper Chase 3: DPP-4 Inhibitors and Heart Failure Risk for Type 2 Diabetes3:38Preoperative Clearance for Noncardiac Surgery21:07The Schedule HackFree Chapter14:45Paper Chase 4: Perioperative Statins Lack Benefit After Cardiac Surgery5:09Amazing Animals: Horseshoe Crab3:33“What To Feed Your Baby”18:05Paper Chase 5: Fluconazole During Pregnancy - Worth the Risk?5:12The Summary15:43
Paper Chase 2: Treating Rheumatoid Arthritis When Methotrexate Monotherapy Fails
No me gusta!
The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.
Triple therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) and most regimens combining biologic DMARDs with methotrexate were effective in controlling disease activity, and all were generally well tolerated in both methotrexate naive and methotrexate exposed patients.